蒙药乌力吉-18对大鼠下丘脑-垂体-卵巢轴相关激素及受体表达的影响

目的:探讨蒙药乌力吉-18对大鼠下丘脑-垂体-卵巢轴相关激素及受体的影响。方法:选取40只健康雌性未孕SD大鼠,随机分为空白组、对照组、乌力吉-18高、低2个剂量组,每组10只。空白组灌胃等体积蒸馏水,对照组灌胃逍遥丸,高、低剂量组分别灌胃2.0 g·kg^-1·d^-1、1.0 g·kg^-1·d^-1乌力吉-18,连续给药31学艺术d。采用酶联免疫吸附法测定血清促性腺激素释放激素(GnRH)、促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E₂)及孕酮(PROG)的含量;免疫组化法检测下丘脑组织促性腺激素释放激素(GnRH)、垂体组织促性腺激素释放激素受体(GnRHR)的表达;以蛋白免疫印迹技术检测卵巢组织促卵泡生成素受体(FSHR)、黄体生成素受体(LHR)蛋白表达量。以实时荧光定量PCR检测卵巢组织中FSHR、LHR基因表达量。结果:与空白组比较,乌力吉-18低剂量组可明显升高血清LH含量(P<0.05),上调下丘脑组织GnRH、垂体组织GnRHR表达及卵巢组织FSHR、LHR蛋白表达(P<0.05);乌力吉-18高剂量组可显著升高血清FSH、LH、E₂含量(P<0.05),上调下丘脑组织GnRH表达及卵巢组织FSHR表达量(P<0.05),并可显著升高卵巢组织中FSHR、LHR基因表达量(P<0.05);对照组可明显升高血清E₂含量(P<0.05)。结论:蒙药乌力吉-18可明显升高血清FSH、LH及E₂的含量,促进下丘脑组织GnRH、垂体组织GnRHR及卵巢组织中FSHR、LHR的表达,表明乌力吉-18能够对下丘脑-垂体-卵巢轴相关激素及受体表达产生影响。     

中华鳖组蛋白H2A变体克隆及其在卵母细胞中的表达分析

为研究组蛋白H2A对龟鳖动物生殖细胞发育分化作用和机制, 克隆了中华鳖(Pelodiscus sinensis)组蛋白H2A变体的同源物(命名为PsH2A), 分析其转录本的表达模式及在卵巢发育成熟过程中的细胞定位。PsH2A cDNA序列全长575 bp, 5′端非编码区68 bp, 3′端非编码区108 bp, 开放阅读框399 bp, 编码133个氨基酸。氨基酸序列比对结果显示其与龟类的H2A变体同源性更高, 与哺乳类同源性较低。RT-qPCR和RT-PCR结果显示, PsH2A转录本在1冬龄、2冬龄和3冬龄的中华鳖卵巢中高表达(P<0.01), 而在精巢和其他成体组织中几乎检测不到。化学原位杂交结果显示, PsH2A mRNA在卵母细胞中特异性表达, 其中初级卵母细胞中表达信号最强, 且均匀的分布在细胞质中。随着卵母细胞发育成熟进入到生长期和成熟期后, 目的信号逐渐减弱, 并且主要在核周区域表达。此外, PsH2A mRNA的相对表达量也表现出中华鳖卵巢发育的季节性变化。综上, 研究结果表明PsH2A在中华鳖卵母细胞发育过程中可能发挥着重要作用。     

大口黑鲈amh基因全长cDNA克隆、表达及多克隆抗体制备

为研究大口黑鲈(Micropterus salmoides)抗缪勒氏管激素(amh)基因的表达及其在性腺发育中的潜在作用,研究利用RACE技术克隆得到了大口黑鲈amh基因,并制备Amh多克隆抗体,通过qRT-PCR、Western Blot分析Amh在大口黑鲈不同组织和不同发育阶段性腺中的表达模式,最后利用HE染色法和免疫组化观察不同发育阶段性腺的形态组织学变化及其与Amh表达的潜在关系。结果显示:大口黑鲈amh基因cDNA序列全长2050 bp,由24 bp5′非编码区、394 bp3′非编码区和1632 bp的开放阅读框组成,共编码543个氨基酸。amh基因mRNA在大口黑鲈11个组织中均有表达,其中雄鱼精巢中表达量最高,肌肉次之,雌鱼卵巢中表达量最高,肌肉次之。amh基因在雌雄鱼不同发育阶段的性腺中表达存在显著差异,精巢中表达量均显著高于卵巢(P<0.05)。同时, Western Blot结果显示Amh蛋白在精巢中表达丰度较高。amh基因在精巢中的表达量呈先上升后下降的趋势,且在孵化后65d鱼精巢中其表达量达到最高(P<0.05),免疫组化结果显示Amh表达于早期精...     

中华鳖vasa基因克隆及在卵母细胞中的表达分析

研究利用中华鳖为研究模型进行爬行类生殖细胞发育分化成熟等生物学研究,克隆了中华鳖vasa基因的cDNA序列,全长3865 bp,包括5'端非编码区90 bp,3'端非编码区1699 bp,开放阅读框长2076 bp,共编码691个氨基酸。中华鳖Vasa氨基酸序列包含DEAD-box家族蛋白8个保守保守功能域,在N末端有4个RGG重复序列和2个GG富集区,与小鼠Vasa蛋白的同源性较高（72%）。荧光定量PCR的结果表明,中华鳖vasa mRNA主要精巢和卵巢中表达,其他体组织中均难检测到表达。卵巢冰冻切片原位杂交结果显示:中华鳖vasa mRNA在生殖细胞中特异表达;在卵子发生过程中的不同发育期卵母细胞中呈现动态的变化。即vasa mRNA在初级卵母细胞及生长期卵母细胞中表达最强,且均匀分布在细胞质中,随着卵母细胞的逐渐增大,信号逐渐减弱,直至在成熟的卵母细胞中几乎检测不到表达信号,说明vasa可能在中华鳖早期卵母细胞发育中起重要作用。同时,vasa基因可作为中华鳖生殖细胞分子标记物,根据其mRNA的表达水平来鉴别不同发育时期的卵母细胞。研究结果为进一步开展中华鳖胚胎生殖细胞发育及配子生成,特别是研究中华鳖,乃至爬行类原始生殖细胞（Primordial Germ Cells,PGCs）的起源、迁移、分化等研究奠定了基础。     

LHRH-A对尼罗罗非鱼生长及生长轴相关基因表达的影响

促性腺激素释放激素(GnRH)的主要作用是刺激脑垂体促性激素(GtH)的释放, 亦可促进鱼类生长激素(GH)的释放。促黄体素释放激素类似物(LHRH-A)是哺乳类GnRH的类似物, 为了分析LHRH-A对尼罗罗非鱼生长调节的作用, 设计了长期和短期2个实验, 采用腹腔注射(剂量0.1 μg/g体重)方法, 分析LHRH-A对尼罗罗非鱼绝对生长率、特定生长率、肝体系数和肥满度的影响, 并应用荧光实时定量PCR方法检测在注射LHRH-A后不同时段(6h、12h、24h、2周)尼罗罗非鱼垂体GH、肝脏GHR和肝脏IGF-I基因的表达变化。结果表明, LHRH-A组尼罗罗非鱼的绝对生长率、特定生长率、肝体系数、肥满度均显著高于对照组(P<0.05); 注射LHRH-A后12h、24h垂体GH mRNA表达水平均显著升高(P<0.05), 2周后恢复到对照组水平; 注射LHRH-A后24h和2周肝脏GHR mRNA表达水平显著上升(P<0.05); 注射LHRH-A后6h肝脏IGF-I mRNA表达水平显著升高(P<0.05), 12h、24h和2周恢复到对照组水平。以上结果提示, LHRH-A可显著上调尼罗罗非鱼生长轴相关基因的表达, 从而促进鱼类的生长。     

光周期对许氏平鲉性腺分化过程中形态学、性激素水平及相关基因表达的影响

研究以35日龄(dpb)许氏平鲉(Sebastes schlegelii)仔稚鱼为对象, 研究不同光周期(短光照组L﹕D=8﹕16、长光照组L﹕D=16﹕8和对照组L﹕D=12﹕12)对性别分化、相关激素水平及基因表达水平的影响。结果显示非自然的光周期尤其是较短的光照, 会不同程度地影响性腺分化时期性腺发育程度, 并且短光照会导致部分性腺雄性化; 雌激素(E₂)在短光照组中更早出现峰值, 而雄激素(T)在3个处理组中均在实验第9天时达到峰值; 4个卵巢分化相关基因cyp19a1a、ERα、ERβ2和foxl2中, ERα、ERβ2和foxl2受短光照影响显著, 实验中后期出现明显的抑制(P<0.05); 4个精巢发育相关基因sox3、sox9、amh和dmrt1相对表达水平未见明显规律, 可能与精巢分化时间较晚有关。综合而言, 较短的光照会影响性腺的发育以及性腺的分化, 抑制卵巢分化基因的表达, 诱导原始性腺雄性化。     

养殖施氏鲟的性腺转录组特征分析

鲟是目前世界上最古老的软骨硬鳞鱼类之一, 雌雄个体之间无明显的第二性征。为了解人工养殖下鲟性腺发育的分子特征, 研究以人工养殖2龄施氏鲟(Acipenser schrenckii Brandt)为研究对象, 对其精巢与卵巢进行转录组测序分析。结果发现, 雌雄性腺中共有19690个差异表达基因转录本, 其中与性别分化相关基因包括转录因子Dmrt1、Sox9、Foxl2等和生长转化因子Amh、Bmp15、Gdf9等。另外, 通过差异表达基因KEGG代谢通路富集分析发现了4条与卵巢发育相关的通路, 分别为黄体酮介导的卵母细胞成熟、卵母细胞减数分裂、卵巢类固醇合成、促性腺激素释放激素信号通路。其中, 卵巢类固醇合成通路中18个差异表达基因的表达模式暗示了2龄施氏鲟限制卵巢雌激素的合成, 但精巢中雄激素的合成未受影响。研究结果为研究鲟性腺分化和发育机制以及今后在mRNA表达水平上鉴定鲟性别提供了基础。     

厄贝沙坦对链脲佐菌素和过氧化氢诱导的β细胞氧化损伤保护作用

目的 探讨厄贝沙坦对链脲佐菌素(STZ)和过氧化氢(H₂O₂)诱导的β细胞损伤影响。方法 (1)将NIT-1细胞分为对照组及1、2、5 mmol/L STZ和300、500μmol/L H₂O₂组,处理30 min后,采用Hoechst 33342法检测各组细胞凋亡形态变化,流式细胞术检测细胞凋亡率,RT-qPCR检测Caspase3 mRNA水平。(2)将NIT-1细胞分为STZ及0.001、0.01、0.1 mmol/L厄贝沙坦组,作用24、48和72 h。(3)将NIT-1细胞分为H₂O₂及0.001、0.01、0.1 mmol/L厄贝沙坦组,作用24、48和72 h。采用流式细胞术检测细胞凋亡率和活性氧(ROS)含量,RT-qPCR检测血管紧张素II型1受体(AT1R)mRNA表达。结果 Hoechst 33342染色显示,5 mmol/L STZ组相较于1、2 mmol/L STZ组,500μmol/L H₂O_2<...     

性类固醇激素对黄颡鱼雌雄生长二态性的影响

为了研究性类固醇激素在雌雄生长二态性中(Sexual Size Dimorphism, SSD)的作用, 文章分析了性类固醇激素对雌雄生长、性腺发育和能量代谢的影响。结果显示: 17β-雌二醇(17β-estradiol, E₂)显著抑制黄颡鱼的生长, 且E₂显著促进能量在肝脏中的分配, 但在摄食量上无显著影响, 所以E2对黄颡鱼生长的抑制是能量分配的差异引起, 而不是能量获取差异引起。17α-甲基睾丸酮(17α-Methyltestosterone, MT)显著促进雌鱼生长, 但抑制雄鱼生长, MT能显著促进黄颡鱼摄食和肝脏的能量分配, 显著抑制卵母细胞的发育和卵巢的能量投入。本研究发现MT通过促进摄食, 抑制卵巢发育并且减少性腺发育的能量投入, 从而促进雌鱼生长; E₂能够显著增加雌雄鱼在肝脏中能量的投入, 最终抑制雌雄生长。实验结果只能部分解释实验中观察到的生长差异现象, 因此我们需要更进一步从能量的摄入、分配及消耗三方面来研究雌雄生长的二态性。     

Effects of 9-ene-tetrahydrocannabinol on expression of β-type transforming growth factors, insulin-like growth factor-I and c-myc genes in the mouse uterus

Effects of cannabinoid on expression of β-type transforming growth factors (TGF-β1, -β2 and -β3), insulin-like growth factor-I (IGF-I) and c-myc genes in the uteri of adult ovariectomized mice were examined using Northern blot hybridization. Mice were exposed to 9-ene-tetrahydrocannabinol (THC) alone or in combination with an injection of estradiol-17β (E₂) and/or progesterone (P₄), and uteri were analyzed at various times thereafter. TGF-β isoform messenger RNAs (mRNAs) persisted in ovariectomized uteri and their levels were not altered after THC treatment, whereas an injection of E₂ caused a modest increase in TGF-β1 and -β3 mRNA levels at 24 h. Imposition of THC treatment advanced the stimulatory effects of E₂ by changing the timing for the peak of TGF-β3 mRNA levels to 12 h. In comparison, E₂ treatment substantially elevated the levels of TGF-β2 mRNA at 6 h, and THC potentiated this E₂ response without affecting the timing for the response. Imposition of P₄ treatment did not antagonize any of these responses. P₄ treatment alone or with THC had insignificant effects on mRNA levels for these TGF-β isoforms. Uterine levels of IGF-I and c-myc mRNAs were low in ovariectomized mice and THC did not alter these mRNA levels. In contrast, E₂ treatment induced a rapid, but transient, increase in IGF-I and c-myc mRNAs, and THC antagonized the rapid c-myc mRNA response and altered the timing of the IGF-I mRNA response. P₄ treatment alone also caused the transient induction of these mRNAs, but THC failed to antagonize these effects. An injection of P₄ plus E₂ resulted in further modest increases in IGF-I and c-myc mRNA levels as compared to E₂ or P₄ treatment alone. However, THC did not antagonize these transient stimulatory effects of the combined ovarian steroids. The data suggest that THC should not be classified as estrogenic or antiestrogenic. However, this compound can modulate (potentiate, antagonize and/or alter timing) the effects of ovarian steroids on uterine gene expression.     

镉、汞暴露在中华绒螯蟹卵巢中的富集及其氧化应激反应

研究以中华绒螯蟹(Eriocheir sinensis)为实验对象, 用不同浓度的Cd2+ 溶液(0、0.63、1.26、2.52、5.04和10.07 mg/L)或Hg2+ 溶液(0、0.06、0.11、0.23、0.46和0.91 mg/L)对其分别进行染毒, 6d后解剖取其卵巢, 检测卵巢中Cd和Hg的富集量以及氧化应激相关指标的变化情况。结果显示, 随着Cd2+或Hg2+染毒浓度的升高, 卵巢中Cd和Hg的富集量显著增加; H₂O₂、MDA和NO含量、MT mRNA表达量及NOS活性均随着Cd2+和Hg2+浓度的增加出现上升的趋势, 但SOD、CAT和GPx活性呈先升后降的趋势。这说明镉、汞均可引起卵巢组织产生过量的自由基和脂质过氧化, 并诱导氧化应激酶及MT mRNA的表达以抵抗不良的环境。总之, MT对中华绒螯蟹卵巢中重金属的解毒发挥着重要作用, 抗氧化酶能有效地消除活性氧自由基(ROS), 维持机体的氧化还原处于平衡状态, 共同保护膜脂免受氧化损伤。     

Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer

Intratumoral levels of E₁ (oestrone), E₁S (oestrone sulphate) and E₂ (oestradiol) are significantly reduced by treatment with the aromatase inhibitor anastrozole regardless of treatment response. The purpose of the present pilot study was to look for additional markers of biochemical response to aromatase inhibitors on mRNA expression level. Whole genome expression was studied using microarray analysis of breast cancer tissue from 12 patients with locally advanced tumors, both before and following 15 weeks of treatment with the aromatase inhibitor anastrozole (Arimidex^®). Intratumoral mRNA levels for a subset of genes coding for steroid metabolizing enzymes, hormone receptors and some growth mediators involved in cell cycle control were analysed by quantitative RT-PCR. There was a correlation between the two methods for some but not all genes. The mRNA expression levels of the different genes were correlated to each other and to the intratumoral levels of E₁, E₂ and E₁S, before and after the treatment. Notably, a correlation of the E₁/E₂ metabolic ratio to the mRNA levels of CYP19A1 was observed before treatment (r = 0.745, p < 0.005). Whole genome expression analysis of these 12 breast cancer patients revealed similar tumor classification to previously published larger studies. Tumors with no or low expression of ESR1 (oestrogen receptor) clustered together and were characterized by a strong basal-like signature highly expressing keratins 5/17, cadherin 3, frizzled and apolipoprotein D, among others. The luminal epithelial tumor cluster, on the other hand, highly expressed ESR1, GATA binding protein 3 and N-acetyl transferase. An evident ERBB2 cluster was observed due to the marked over-expression of the ERBB2 gene and GRB7 and PPARBP in this patient material). Using significance analysis of microarrays (SAM), we identified 298 genes significantly differently expressed between the partial response and progressive disease groups.     

Kinetic analysis of enzymic activities: Prediction of multiple forms of 17β-hydroxysteroid dehydrogenase

An overview of the application of kinetic methods to the delineation of 17β-hydroxysteroid dehydrogenase (17β-HSD) heterogeneity in mammalian tissues is presented. Early studies of 17β-HSD activity in animal liver and kidney subcellular fractions were suggestive of multiple forms of the enzyme. Subsequently, detailed characterization of activity in cytosol and subcellular membrane fractions of human placenta, with particular emphasis on inhibition kinetics, yielded evidence of two kinetically-differing forms of 17β-HSD in that organ. Gene cloning and transfection experiments have confirmed the identity of these two proteins as products of separate genes. 17β-HSD type 1 is a cytosolic enzyme highly specific for C₁₈ steroids such as 17β-estradiol (E₂) and estrone (E₁). 17β-HSD type 2 is a membrane bound enzyme reactive with testosterone (T) and androstenedione (A), as well as E₂ and E₁. Useful parameters for the detection of multiple forms of 17β-HSD appear to be the E₂/T activity ratio, NAD/NADP activity ratios, steroid inhibitor specificity and inhibition patterns over a wide range of putative inhibitor concentrations. Evaluation of these parameters for microsomes from samples of human breast tissue suggests the presence of 17β-HSD type 2. The 17β-HSD enzymology of human testis microsomes appears to differ from placenta. Analysis of human ovary indicates granulosa cells are particularly enriched in the type 1 enzyme with type 2-like activity in stroma/theca. Mouse ovary appears to contain forms of 17β-HSD which differ from 17β-HSD type 1 and type 2 in their kinetic properties.